BASAL CELL CARCINOMA: WHEN EXCISION IS NOT AN OPTION

Alina Suru, George Sorin Tiplica, Carmen Maria Salavastru

Abstract


Basal cell carcinomas are the most common malignant skin tumors. The clinical aspect underlying this type of tumor ranges from millimeter lesions to large, ulcerated tumors. Although surgery remains the gold standard of treatment for most of the high-risk tumors, recent nonsurgical and topical therapies, used in mono- or combination therapy have offered a new perspective in the treatment of basal cell carcinoma. Causes related to patient's associated pathology, location and tumor characteristics, recovery times, costs, and patient's desire have led to the exploration of other treatment options.
In this paper we propose to revise the current indications for treatment of basal cell carcinomas, the international experience of combined therapies as it appears from articles published in specialized journals. 

Key words: basal cell carcinoma, topical therapies, combined therapies, laser, surgery.

Cite this article:
Alina Suru, Ionela Manole, George Sorin Ţiplica, Carmen Maria Sălăvăstru. Basal cell carcinoma: when excision is not an option.
RoJCED 2017;3(4):130-133. https://doi.org/10.26574/rojced.2017.4.3.130 

 


Full Text:

PDF

Refbacks

  • There are currently no refbacks.




Copyright (c) 2017 Romanian Journal of Clinical and Experimental Dermatology

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

—Print : ISSN 2392–7461, ISSN-L 2392–7461 
—Online : ISSN 2392-8697, ISSN-L 2392-7461

Editor-In-Chief and Managing Editor - Victor Gabriel Clatici
 

 

 

Creative Commons License
Romanian Journal of Clinical and Experimental Dermatology by Tarus Media is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Based on a work at http://www.rojced.com/index.php/rojced/index.
Permissions beyond the scope of this license may be available at tarusmedia.ro